GO:0050727 regulation of inflammatory response: Signaling Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0050727 regulation of inflammatory response describes any biological process that modulates the frequency, rate, or extent of the inflammatory response, the immediate defensive reaction of vertebrate tissue to infection or injury.
• Inflammatory responses are tightly controlled at multiple levels, including ubiquitination-dependent signaling, transcriptional regulation of inflammasomes, and non-coding RNA networks.
• Dysregulation of inflammatory response regulation contributes to cancer, post-acute COVID-19 syndrome, ulcerative colitis, and placental pathologies.
• Key molecular players include inflammasome components, MEF2D, PGC-1α, and ubiquitin-modifying enzymes that set inflammatory thresholds.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of regulatory nodes in inflammatory pathways.
• Transcriptomic, proteomic, and imaging methods combined with CRISPR library screening allow systematic mapping of inflammatory regulatory networks.
Description
The inflammatory response is a fundamental protective reaction of vertebrate tissues to infection, injury, or chemical and physical agents. However, inflammation must be precisely regulated because excessive or unresolved inflammation drives tissue damage and chronic disease. GO:0050727, regulation of inflammatory response, captures any process that modulates the frequency, rate, or extent of this defensive reaction. Understanding this ontology term is essential for researchers studying host defense, autoimmunity, cancer, and tissue repair. The regulatory mechanisms span ubiquitination-dependent signaling, transcriptional control of inflammasome components, non-coding RNA networks, and metabolic regulators such as PGC-1α. These layers ensure that inflammation is initiated when needed and resolved promptly. Disruption of these regulatory circuits is linked to diverse pathologies, including cancer, post-acute COVID-19 syndrome, ulcerative colitis, and placental disorders. Consequently, GO:0050727 is a central node for both basic immunology and translational research. This article provides a research-grade overview of the term, its mechanisms, key genes, disease relevance, and experimental strategies for studying inflammatory regulation.
regulation of inflammatory response At A Glance
| GO ID | GO:0050727 |
|---|---|
| GO term | regulation of inflammatory response |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the frequency, rate, or extent of the inflammatory response to infection or injury |
| Definition source | QuickGO definition: Any process that modulates the frequency, rate or extent of the inflammatory response, the immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. |
| Related processes | Ubiquitination, inflammasome transcriptional regulation, non-coding RNA networks, mitochondrial ROS stress response |
| Disease relevance | Cancer, post-acute COVID-19 syndrome, ulcerative colitis, placental pathologies |
What Is GO:0050727?
GO:0050727 regulation of inflammatory response is defined as any process that modulates the frequency, rate, or extent of the inflammatory response, which is the immediate defensive reaction by vertebrate tissue to infection or injury caused by chemical or physical agents. In practice, this term encompasses molecular events that either amplify or suppress inflammatory signaling, including ubiquitination, transcriptional control, non-coding RNA activity, and metabolic regulation.
Why Is regulation of inflammatory response Important in Cell Biology?
Regulation of inflammatory response is critically important because it determines whether inflammation resolves or becomes chronic, a decision that impacts outcomes in cancer, infectious disease, autoimmunity, and tissue repair. Mechanistic understanding of this GO term enables identification of therapeutic targets and biomarkers for inflammatory disorders.
• Controls the balance between protective immunity and tissue-damaging inflammation.
• Ubiquitination pathways within this term regulate inflammatory cell death and cancer progression.
• Non-coding RNAs modulate endotoxin tolerance and compensatory anti-inflammatory response syndrome.
• Transcriptional regulation of inflammasomes is a key node in inflammatory response control.
• MEF2D regulation of IFN-Is in microglia promotes inflammatory homeostasis in the central nervous system.
• PGC-1α links mitochondrial lifecycle and ROS stress response to inflammatory regulation.
• Dysregulation is associated with post-acute COVID-19 syndrome and persistent inflammation.
• Macrophage-biomimetic nanomedicine targeting inflammatory regulation ameliorates ulcerative colitis.
• Cell polarity signaling regulates syncytiotrophoblast homeostasis and inflammatory response in the placenta.
• Provides a framework for CRISPR-based functional genomics of inflammatory pathways.
What Happens During regulation of inflammatory response?
Initiation and sensing of inflammatory triggers
In simple terms: The body detects infection or injury and starts an inflammatory alarm.
Inflammatory responses begin when vertebrate tissues sense infection or injury caused by chemical or physical agents. This sensing activates signaling cascades that include ubiquitination-dependent events, which are critical for propagating inflammatory cell death and cancer-related inflammation. Transcriptional programs also ramp up inflammasome components, which are key platforms for inflammatory cytokine maturation.
Transcriptional control of inflammasome and cytokine genes
In simple terms: Cells turn inflammation genes on or off at the DNA level.
Transcriptional regulation of inflammasomes determines the availability of key inflammatory sensors and effectors. This layer of control ensures that inflammasome components are expressed at appropriate levels to respond to danger signals without causing spontaneous inflammation. Non-coding RNAs also participate in this transcriptional and post-transcriptional regulation, influencing endotoxin tolerance and compensatory anti-inflammatory responses.
Post-translational modification and ubiquitination
In simple terms: Small tags are added to proteins to switch inflammation up or down.
Ubiquitination is a central post-translational mechanism that regulates inflammatory cell death and cancer. Ubiquitin-modifying enzymes add or remove ubiquitin chains on signaling proteins, thereby controlling the stability, localization, and activity of inflammatory mediators. This layer provides rapid and reversible control of inflammatory response intensity.
Metabolic and mitochondrial regulation
In simple terms: Cell energy and stress pathways tune inflammation.
PGC-1α is a master regulator of mitochondrial lifecycle and ROS stress response, linking metabolic status to inflammatory regulation. Mitochondrial dysfunction and oxidative stress can amplify or dampen inflammatory signaling, and PGC-1α-dependent pathways help maintain inflammatory homeostasis.
Resolution and homeostasis
In simple terms: Inflammation is turned off once the threat is gone.
Resolution of inflammation involves active suppression of inflammatory signaling and restoration of tissue homeostasis. MEF2D regulation of IFN-Is in microglia promotes inflammatory homeostasis in the central nervous system. Cell polarity signaling also contributes to syncytiotrophoblast homeostasis and inflammatory response regulation in the placenta. Failure of resolution leads to chronic inflammatory states such as post-acute COVID-19 syndrome.
Key Genes Involved in GO:0050727 regulation of inflammatory response
The following genes and proteins are experimentally implicated in the regulation of inflammatory response (GO:0050727) based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Ubiquitin-modifying enzymes | Add or remove ubiquitin chains on inflammatory signaling proteins | Regulate inflammatory cell death and cancer |
| PGC-1α (PPARGC1A) | Master regulator of mitochondrial lifecycle and ROS stress response | Links metabolism to inflammatory regulation |
| Non-coding RNAs | Modulate endotoxin tolerance and compensatory anti-inflammatory response | Regulate inflammatory gene expression |
| MEF2D | Regulates IFN-Is in microglia | Promotes inflammatory homeostasis in CNS |
| Inflammasome components | Platforms for inflammatory cytokine maturation | Transcriptional regulation of inflammasomes |
| Cell polarity signaling proteins | Regulate syncytiotrophoblast homeostasis | Inflammatory response in placenta |
| Macrophage-biomimetic nanomedicine targets | Ameliorate ulcerative colitis via inflammatory regulation | Therapeutic targeting of inflammation |
| IFN-I signaling proteins | Type I interferon responses in microglia | Inflammatory homeostasis |
| ROS stress response proteins | Mitochondrial ROS management | Inflammatory regulation |
| Ubiquitin ligases | Target inflammatory proteins for degradation | Inflammatory cell death and cancer |
| Deubiquitinases | Remove ubiquitin chains from inflammatory proteins | Inflammatory signaling |
| Inflammasome sensors | Detect danger signals | Transcriptional regulation |
| Cytokine genes | Pro- and anti-inflammatory mediators | Endotoxin tolerance |
| Trophoblast polarity proteins | Maintain placental homeostasis | Inflammatory response in placenta |
| Microglial IFN-I regulators | Control neuroinflammation | CNS inflammatory homeostasis |
| Mitochondrial biogenesis regulators | Control mitochondrial lifecycle | ROS stress response |
| Nanomedicine payload targets | Modulate macrophage inflammatory activity | Ulcerative colitis therapy |
How Is regulation of inflammatory response Regulated?
Regulation of inflammatory response is itself controlled by multiple layers. Ubiquitination and deubiquitination provide rapid post-translational control of inflammatory signaling proteins. Transcriptional regulation of inflammasomes determines the capacity for inflammatory cytokine production. Non-coding RNAs modulate endotoxin tolerance and compensatory anti-inflammatory responses. Metabolic regulators such as PGC-1α integrate mitochondrial function and ROS stress response with inflammatory pathways. MEF2D-dependent IFN-I regulation in microglia maintains inflammatory homeostasis in the CNS. Cell polarity signaling contributes to syncytiotrophoblast homeostasis and inflammatory response regulation.
regulation of inflammatory response and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Ubiquitin-modifying enzymes | Cancer and inflammatory cell death | Knockout and point-mutation cell models |
| PGC-1α (PPARGC1A) | Metabolic and inflammatory disorders | Overexpression and knockout models |
| MEF2D | Neuroinflammation | Knockout and knock-in microglial models |
| Inflammasome components | Autoinflammatory diseases | Knockout and point-mutation models |
| Non-coding RNAs | Endotoxin tolerance and CARS | Overexpression and knockdown models |
Cancer and inflammatory cell death
Ubiquitination pathways that regulate inflammatory cell death are directly implicated in cancer. Dysregulation of these pathways can promote tumorigenesis by altering inflammatory signaling and cell death decisions.
Post-acute COVID-19 syndrome
Post-acute COVID-19 syndrome is characterized by persistent inflammation and multi-organ symptoms. Dysregulated inflammatory response regulation contributes to the chronic inflammatory state observed in affected individuals.
Ulcerative colitis
Ulcerative colitis involves chronic intestinal inflammation. Macrophage-biomimetic nanomedicine ameliorates ulcerative colitis via inflammatory regulation, demonstrating the therapeutic potential of targeting this process.
Placental pathologies
Cell polarity signaling regulates syncytiotrophoblast homeostasis and inflammatory response in the placenta. Disruption of these regulatory mechanisms may contribute to placental dysfunction and pregnancy complications.
From regulation of inflammatory response-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene regulate inflammatory response? | CRISPR knockout cell model |
| Does a specific point mutation alter inflammatory signaling? | CRISPR point-mutation knock-in |
| Does overexpression of a regulator suppress inflammation? | CRISPR overexpression model |
| Does a tagged protein localize to inflammatory signaling complexes? | Tagged knock-in |
| Which genes modulate inflammasome transcription? | CRISPR library screening |
| How do non-coding RNAs affect endotoxin tolerance? | Overexpression and knockout models |
How to Study the regulation of inflammatory response Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global transcriptome changes | Identify inflammatory gene expression programs |
| Proteomics | Protein abundance and modifications | Quantify ubiquitination in inflammatory signaling |
| Ubiquitinome profiling | Ubiquitin chain topology and targets | Map regulatory ubiquitination events |
| Live-cell imaging | Real-time signaling dynamics | Visualize inflammasome assembly |
| CRISPR knockout screening | Gene essentiality in inflammatory response | Identify novel regulators |
| CRISPR activation (overexpression) | Gain-of-function effects | Test sufficiency of candidate regulators |
| Reporter assays | Transcriptional activity of inflammatory promoters | Measure NF-κB or IFN-I activity |
Transcriptomic profiling
RNA-seq and related transcriptomic methods measure global changes in inflammatory gene expression following genetic or pharmacological perturbation. These approaches help identify regulatory nodes within GO:0050727.
Proteomic and ubiquitinome analysis
Proteomics and ubiquitinome profiling quantify protein abundance and ubiquitination status, revealing post-translational regulatory events in inflammatory signaling.
Imaging and reporter assays
Live-cell imaging and reporter assays visualize inflammatory signaling dynamics, including NF-κB activation and inflammasome assembly, in response to stimuli.
CRISPR functional genomics
CRISPR knockout, point-mutation, knock-in, and overexpression screens systematically test the causal role of genes in regulating inflammatory response.
How CRISPR Can Be Used to Study GO:0050727 regulation of inflammatory response
Knockout
CRISPR knockout generates loss-of-function models to test whether a candidate gene is required for regulation of inflammatory response. This approach is widely used to dissect ubiquitination-dependent and inflammasome-related pathways.
Point Mutation
CRISPR point mutation introduces specific amino acid changes to probe the function of individual residues in inflammatory regulatory proteins, such as ubiquitin acceptor sites or catalytic cysteines.
Knock-in
CRISPR knock-in enables tagging or replacement of endogenous genes with reporters or epitope tags, allowing visualization and biochemical analysis of inflammatory regulators at native loci.
Overexpression
CRISPR overexpression (e.g., CRISPRa) drives supraphysiological expression of candidate genes to test sufficiency for modulating inflammatory response, as demonstrated for metabolic regulators like PGC-1α.
How EDITGENE Supports regulation of inflammatory response Research
Researchers studying regulation of inflammatory response-related genes often need to determine whether a candidate gene is causally involved in modulating inflammation. EDITGENE provides comprehensive CRISPR-based services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support, enabling rigorous functional dissection of GO:0050727.
Contact EDITGENE today to design your custom CRISPR model for regulation of inflammatory response research.
Frequently Asked Questions About regulation of inflammatory response
What is GO:0050727 regulation of inflammatory response?
GO:0050727 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate, or extent of the inflammatory response, the immediate defensive reaction by vertebrate tissue to infection or injury caused by chemical or physical agents.
What genes are involved in regulation of inflammatory response?
Genes and proteins involved include ubiquitin-modifying enzymes, PGC-1α, MEF2D, inflammasome components, non-coding RNAs, and cell polarity signaling proteins.
How is inflammatory response regulated?
Inflammatory response is regulated at multiple levels, including ubiquitination-dependent signaling, transcriptional control of inflammasomes, non-coding RNA networks, and metabolic regulation by PGC-1α.
What diseases are linked to dysregulated inflammatory response?
Dysregulated inflammatory response is linked to cancer, post-acute COVID-19 syndrome, ulcerative colitis, and placental pathologies.
What is the role of ubiquitination in inflammatory response?
Ubiquitination regulates inflammatory cell death and cancer by controlling the stability, localization, and activity of inflammatory signaling proteins.
How do non-coding RNAs regulate inflammation?
Non-coding RNAs modulate endotoxin tolerance and compensatory anti-inflammatory response syndrome by regulating inflammatory gene expression.
What is the role of MEF2D in inflammation?
MEF2D regulates IFN-Is in microglia to promote inflammatory homeostasis in the central nervous system.
How does PGC-1α affect inflammatory response?
PGC-1α is a master regulator of mitochondrial lifecycle and ROS stress response, linking metabolic status to inflammatory regulation.
What experimental models are used to study regulation of inflammatory response?
CRISPR knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening, are used to study inflammatory regulation.
How can CRISPR help study inflammatory response regulation?
CRISPR enables loss-of-function, gain-of-function, and precise mutation models to test causal roles of genes in regulating inflammatory response.
Conclusion
GO:0050727 regulation of inflammatory response is a central biological process that controls the intensity and duration of inflammation. Its molecular underpinnings involve ubiquitination, transcriptional control of inflammasomes, non-coding RNAs, and metabolic regulators such as PGC-1α. Dysregulation of this process contributes to cancer, post-acute COVID-19 syndrome, ulcerative colitis, and placental pathologies. CRISPR-based models and functional genomics provide powerful tools to dissect these regulatory networks and identify therapeutic targets.
References
- 1. Cockram PE et al.. 2021. Ubiquitination in the regulation of inflammatory cell death and cancer.. Cell Death Differ 28(2):591-605 PMID: 33432113
- 2. Abu Shelbayeh O et al.. 2023. PGC-1α Is a Master Regulator of Mitochondrial Lifecycle and ROS Stress Response.. Antioxidants (Basel) 12(5) PMID: 37237941
- 3. Vergadi E et al.. 2018. Regulation of Endotoxin Tolerance and Compensatory Anti-inflammatory Response Syndrome by Non-coding RNAs.. Front Immunol 9:2705 PMID: 30515175
- 4. Nalbandian A et al.. 2021. Post-acute COVID-19 syndrome.. Nat Med 27(4):601-615 PMID: 33753937
- 5. Lu F et al.. 2021. Regulation of IFN-Is by MEF2D Promotes Inflammatory Homeostasis in Microglia.. J Inflamm Res 14:2851-2863 PMID: 34234510
- 6. Shaha S et al.. 2023. Cell polarity signaling in the regulation of syncytiotrophoblast homeostasis and inflammatory response.. Placenta 141:26-34 PMID: 36443107
- 7. Sun T et al.. 2020. Amelioration of ulcerative colitis via inflammatory regulation by macrophage-biomimetic nanomedicine.. Theranostics 10(22):10106-10119 PMID: 32929337
- 8. Cornut M et al.. 2020. Transcriptional Regulation of Inflammasomes.. Int J Mol Sci 21(21) PMID: 33138274
